Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Vermont
With
University of Vermont Medical Center
Age
40–65
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Post-menopausal (last period 12 mos prior to study enrollment or oophorectomy)
Age 40-65
DCIS, Stage I, II, III Breast Cancer
BMI between 27-50
Completed chemotherapy to treat early stage breast cancer (Stage I-III) no less then 6 months and no more than 48 months from start of study or for specific aim 3 Diagnosis of DCIS or Stage I breast cancer who did not receive chemotherapy.
You may not be if
Participant can not have a psychotic or central nervous system impairment that would limit compliance with study requirements
Evidence of metastatic disease
Chemotherapy for cancer other than breast cancer
Diabetes mellitus, uncontrolled hypo or hyper thyroidism, liver failure
Celiac sprue, inflammatory bowel disease
Inability to walk for exercise
Lymphedema as indicated by a 2 cm circumference difference at the elbow
weight loss in the previous 6 months of 10 lbs or greater
Clareo Health | Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors
